文献速递流行病学与生物统计

超越传统分层分析:从比较性随机临床研究数据估计总体疗效

Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study.
PubMed 文献 · Stat Med · 2018-10-23

针对两组比较研究,传统分层推断方法(如Cochran-Mantel-Haenszel统计量和分层Cox程序)在层间治疗分配比例差异明显时,可能不如简单两样本估计。本文研究两样本朴素估计量在辅助统计量条件下的随机性质,提出一种偏倚校正估计量,该估计量与无条件设置下的增强估计量渐近等价,且等价于先按层大小加权平均估计各组平均反应再构建组间对比的简单程序。该程序灵活,可通过选择层权重适用于任何目标患者人群,并用治疗分配不平衡的心血管临床试验数据说明。

要点

  • 传统分层方法在层间治疗分配比例差异大时可能精度不如简单两样本估计。
  • 提出的偏倚校正估计量与增强估计量渐近等价,且等价于层大小加权平均的简单程序。
  • 该简单程序可通过选择层权重灵活适用于不同目标患者人群。

核心结论

  • 在层间治疗分配比例差异明显时,传统分层方法可能不如两样本估计,提出的偏倚校正估计量可提高估计精度。

研究设计与样本

  • 方法学研究,基于比较性随机临床研究数据,以心血管临床试验数据为例说明。

主要发现

  • Cochran-Mantel-Haenszel统计量和分层Cox程序在治疗分配跨层不平衡时可能劣于两样本对应方法。
  • 偏倚校正估计量与无条件设置下的增强估计量渐近等价。
  • 该估计量等价于先按层大小加权平均估计各组平均反应再构建组间对比的简单程序。

临床怎么用

  • 当层间治疗分配比例差异明显时,可考虑使用偏倚校正估计量或层大小加权平均的简单程序估计总体疗效。
  • 通过选择适当的层权重,该简单程序可灵活应用于特定目标患者人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For a two-group comparative study, a stratified inference procedure is routinely used to estimate an overall group contrast to increase the precision of the simple two-sample estimator. Unfortunately, most commonly used methods including the Cochran-Mantel-Haenszel statistic for a binary outcome and the stratified Cox procedure for the event time endpoint do not serve this purpose well. In fact, these procedures may be worse than their two-sample counterparts even when the observed treatment allocations are imbalanced across strata. Various procedures beyond the conventional stratified methods have been proposed to increase the precision of estimation when the naive estimator is consistent. In this paper, we are interested in the case when the treatment allocation proportions vary markedly across strata. We study the stochastic properties of the two-sample naive estimator conditional on the ancillary statistics, the observed treatment allocation proportions and/or the stratum sizes, and present a biased-adjusted estimator. This adjusted estimator is asymptotically equivalent to the augmentation estimators proposed under the unconditional setting. Moreover, this consistent estimation procedure is also equivalent to a rather simple procedure, which estimates the mean response of each treatment group first via a stratum-size weighted average and then constructs the group contrast estimate. This simple procedure is flexible and readily applicable to any target patient population by choosing appropriate stratum weights. All the proposals are illustrated with the data from a cardiovascular clinical trial, whose treatment allocations are imbalanced.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Tian L, Jiang F, Hasegawa T, et al. Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study. Stat Med. 2018. PMID: 30352486. doi:10.1002/sim.8015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。